12060643

Source:http://linkedlifedata.com/resource/pubmed/id/12060643

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0205314, umls-concept:C0441655, umls-concept:C0441833, umls-concept:C0450442, umls-concept:C0599894, umls-concept:C0679622, umls-concept:C1122629, umls-concept:C1710493, umls-concept:C1801960, umls-concept:C1999270
pubmed:issue	6
pubmed:dateCreated	2002-6-12
pubmed:abstractText	The purpose of this study was to examine the antitumor effects of the novel vascular targeting agent ZD6126 and to use histology, CD31 immunohistochemistry, and electron microscopy to gain an insight into the mechanism of action of this novel agent.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9502500
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD31, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations, http://linkedlifedata.com/resource/pubmed/chemical/N-acetylcochinol-O-phosphate, http://linkedlifedata.com/resource/pubmed/chemical/Organophosphorus Compounds
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	1078-0432
pubmed:author	pubmed-author:AshtonSue ESE, pubmed-author:BlakeyDavid CDC, pubmed-author:DavisPeter DPD, pubmed-author:HughesGareth DGD, pubmed-author:RyanAnderson JAJ, pubmed-author:WalkerMikeM, pubmed-author:WestwoodF RussellFR
pubmed:issnType	Print
pubmed:volume	8
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1974-83
pubmed:dateRevised	2004-11-17
pubmed:meshHeading	pubmed-meshheading:12060643-3T3 Cells, pubmed-meshheading:12060643-Animals, pubmed-meshheading:12060643-Antigens, CD31, pubmed-meshheading:12060643-Antineoplastic Agents, pubmed-meshheading:12060643-Apoptosis, pubmed-meshheading:12060643-Cell Division, pubmed-meshheading:12060643-Cisplatin, pubmed-meshheading:12060643-Dose-Response Relationship, Drug, pubmed-meshheading:12060643-Drug Combinations, pubmed-meshheading:12060643-Drug Synergism, pubmed-meshheading:12060643-Endothelium, Vascular, pubmed-meshheading:12060643-Female, pubmed-meshheading:12060643-Humans, pubmed-meshheading:12060643-Immunoenzyme Techniques, pubmed-meshheading:12060643-Male, pubmed-meshheading:12060643-Mice, pubmed-meshheading:12060643-Mice, Nude, pubmed-meshheading:12060643-Neoplasms, Experimental, pubmed-meshheading:12060643-Neovascularization, Pathologic, pubmed-meshheading:12060643-Organophosphorus Compounds, pubmed-meshheading:12060643-Tumor Cells, Cultured
pubmed:year	2002
pubmed:articleTitle	Antitumor activity of the novel vascular targeting agent ZD6126 in a panel of tumor models.
pubmed:affiliation	Cancer and Infection Bioscience Department, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK. david.blakey@astrazeneca.com
pubmed:publicationType	Journal Article